- Investing Ideas
- /
- Swedish Fast Growing Stocks With High Insider Ownership
Swedish Fast Growing Stocks With High Insider Ownership
UPDATED Jun 29, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
86 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CALTX | SEK 205.60 | 0.4% | 137.1% | SEK 11.0b | SEK 221.25 | PS8.4x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.61 | -3.6% | 27.8% | SEK 436.6m | SEK 2.20 | PS4.7x | E90.4% | n/a | Tech | ||
YUBICO | SEK 226.50 | -2.2% | 130.2% | SEK 19.5b | SEK 265.00 | PE117.8x | E43.8% | n/a | Software | ||
YIELD | SEK 2.49 | 1.6% | -66.5% | SEK 142.6m | SEK 9.00 | PB1.7x | E103.4% | n/a | Diversified Financials | ||
SILEON | SEK 0.56 | -6.7% | -87.9% | SEK 28.4m | n/a | PB1.8x | E109.3% | n/a | Software | ||
CTT | SEK 323.00 | -7.4% | 52.4% | SEK 4.0b | n/a | PE39.7x | E21.6% | 1.7% | Capital Goods | ||
BIOA B | SEK 228.80 | 5.9% | -18.9% | SEK 20.2b | SEK 368.00 | PS80.1x | E50.9% | 0% | Pharmaceuticals & Biotech | ||
EDYOU | SEK 0.52 | 8.6% | -40.9% | SEK 19.3m | n/a | PB0.3x | E63.1% | n/a | Media | ||
BIOVIC B | SEK 2.75 | 5.8% | -59.5% | SEK 231.2m | SEK 7.90 | PS31.7x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.56 | -4.8% | -28.7% | SEK 276.9m | SEK 3.65 | PS2.9x | E104.9% | n/a | Tech | ||
ORGC | SEK 3.84 | 1.3% | -17.4% | SEK 376.8m | SEK 3.00 | PS2.7x | E103.3% | n/a | Materials | ||
CRAD B | SEK 43.60 | 4.7% | 59.1% | SEK 1.5b | SEK 56.00 | PE30.4x | E30.4% | n/a | Healthcare | ||
ORT B | SEK 8.38 | 2.2% | 13.6% | SEK 310.8m | SEK 18.00 | PS4.9x | E62.8% | n/a | Healthcare | ||
MIDS | SEK 1.84 | 0.7% | -31.3% | SEK 386.3m | SEK 2.80 | PS6x | E89.9% | n/a | Semiconductors | ||
SENZA | SEK 7.20 | 3.6% | -36.3% | SEK 212.4m | SEK 17.25 | PS4.1x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
KLAR | SEK 0.44 | 10.3% | -37.0% | SEK 57.1m | SEK 1.00 | PB2x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
EGTX | SEK 4.67 | -25.5% | 8.6% | SEK 1.4b | SEK 13.30 | PS21.7x | E99.0% | n/a | Pharmaceuticals & Biotech | ||
QLIRO | SEK 23.00 | 6.7% | -3.8% | SEK 438.7m | SEK 21.00 | PE68.5x | E71.9% | n/a | Diversified Financials | ||
FNOX | SEK 63.98 | 3.5% | 0.5% | SEK 39.0b | SEK 73.78 | PE63.7x | E21.1% | 0.3% | Software | ||
NIUTEC | SEK 6.74 | 7.0% | -40.7% | SEK 133.9m | SEK 9.50 | PB1.6x | E94.1% | n/a | Capital Goods | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
NAVIGO STAM | SEK 4.07 | -7.9% | n/a | SEK 519.1m | n/a | PE658.2x | E77.4% | n/a | Diversified Financials | ||
ASAI | SEK 0.56 | -6.7% | -52.4% | SEK 207.1m | n/a | PS2.4x | E66.6% | n/a | Software | ||
LIME | SEK 350.00 | 6.7% | 28.0% | SEK 4.6b | SEK 353.33 | PE54x | E21.5% | 1.0% | Software |